Emtricitabine | compare suppliers & send inquiries for free
Looking for Emtricitabine 143491-57-0?
- API | Excipient name:
- Emtricitabine
- Synonyms:
- Emtricitabin, Emtricitabina, Emtricitabine, Emtricitabine, Emtricitabinum
- Cas Number:
- 143491-57-0
- DrugBank number:
- DB00879
- Unique Ingredient Identifier:
- G70B4ETF4S
About Emtricitabine
Want to know what Emtricitabine is used for? Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) indicated for the treatment of HIV infection in adults5 or combined with tenofovir alafenamide for the prevention of HIV-1 infection in high risk adolescents and adults. Emtricitabine is a cytidine analogue. The drug works by inhibiting HIV reverse transcriptase, preventing transcription of HIV RNA to DNA. Emtricitabine was granted FDA approval on 2 July 2003.
You can ask the supplier about all relevant certificates for the product such as CoA, Safety Data Sheet and DMF.
Emtricitabine manufacturers | traders | suppliers
We have 17 companies offering Emtricitabine from 6 different countries.
Get in contact with the supplier of your choice:
- Beijing THTD Pharmaceutical Technology Co., Ltd. from China
- TIEFENBACHER API + Ingredients from Germany
- Lupin from India
- DKSH from Switzerland
- Hangzhou Coben Pharmaceutical Co Ltd from China
- Aurobindo from India
- Mylan from India
- Anhui Biochem United Pharma from China
- Macleods Pharma from India
- Hetero Labs from India
- Uquifa from Spain
- Laurus Labs from India
- Cipla from India
- Shanghai Desano Chem. from China
- Cambrex from Italy
- Xiamen Fine Chemical from China
- Shanghai Acebright from China
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.